Abstract: Provided herein are phosphodiesterase 4D (PDE4D) inhibitors, including methods of using the same. Also provided are methods of treating subjects suffering from conditions associated with aberrant PDE activity.
Type:
Grant
Filed:
April 23, 2020
Date of Patent:
August 31, 2021
Assignee:
TETRA DISCOVERY PARTNERS, INC.
Inventors:
Mark E. Gurney, Xuesheng Mo, Richard Allen Nugent, Donna Lee Romero